期刊文献+

多囊卵巢综合征患者血清CRP与心血管危险因素关系研究

The study of serum high sensitive C-reactive protein and its relationship with cardiovascular risk factors in normoinsulinemic polycystic ovary patients
下载PDF
导出
摘要 目的:研究非胰岛素抵抗且不伴有代谢综合征多囊卵巢综合征(PCOS)患者血清HS-CRP水平的变化,探讨HS-CRP与心血管危险因素之间的关系。方法:收集53例PCOS患者及47例正常女性的临床资料,检测血清内分泌激素、空腹血糖、空腹胰岛素、血脂和HS-CRP水平。结果:PCOS患者与对照组相比,WHR、睾酮、LDL、TC、TG和HS-CRP显著升高,HDL显著降低(P<0.05)。HS-CRP与BMI(r=0.45,P<0.0001)、WHR(r=0.68,P<0.0001)、LDL(r=0.63,P<0.0001)、TC(r=0.55,P<0.0001)和TG(r=0.34,P<0.0001)呈正相关,与HDL(r=-0.45,P<0.0001)呈负相关。HS-CRP与PCOS疾病状态之间也有相关性(r=0.71,P<0.001)。多元线性回归分析显示,BMI、WHR、LDL、HDL和PCOS疾病状态是影响HS-CRP独立因素。结论:血清胰岛素正常且不伴有胰岛素抵抗的PCOS患者血清HS-CRP水平升高,升高的HS-CRP与心血管危险因素相关。 Objective:To investigate serum high sensitive C-reactive protein(HS-CRP) levels in normoinsulinemic polycystic ovary syndrome(PCOS) patients without metabolic syndrome and whether there was any relationship between HS-CRP and other cardiovascular risk factors.Methods:53 normoinsulinemic PCOS patients without metabolic syndrome and 47 normoandrogenic ovulatory women were recruited.All the participants underwent standard clinical examinations and ultrasonograpic.Serum endocrine hormone,lipid,glucose,insulin and HS-CRP levels were measured.Results:PCOS patients had increased HS-CRP compared to the control group(P〈0.0001).HS-CRP was positively correlated with body mass index(BMI)(r=0.45,P〈0.0001),waist-to-hip ratio(WHR)(r=0.68,P〈0.0001),LDL(r=0.63,P〈0.0001),TC(r=0.55,P〈0.0001)and TG(r=0.34,P〈0.0001),and negatively correlated with HDL(r=-0.45,P〈0.0001).There was also a strong association between HS-CRP and PCOS status(r=0.71,P〈0.0001)in the study.Multivariate regression analysis demonstrated that BMI,WHR,LDL,HDL and PCOS status were also the independent variables that influenced HS-CRP in the overall group.Conclusion:Elevated HS-CRP was associated with cardiovascular risk factors in normoinsulinemic PCOS without metabolic syndrome.
作者 尚强
出处 《中国民康医学》 2010年第18期2313-2314,2347,共3页 Medical Journal of Chinese People’s Health
关键词 胰岛素抵抗 代谢综合征 多囊卵巢综合征 心血管危险因素 Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome; Cardiovascular risk
  • 相关文献

参考文献10

  • 1Ehrmann DA.Polycystic ovary syndrome[J].N Engl J Med,2005,352:1223-1236.
  • 2Giallauria F,Orio F,Palomba S,et al.Cardiovascular risk in women with polycystic ovary syndrome[J].J Cardiovasc Med,2008,9:987-992.
  • 3Kelly CC,Lyall H,Petrie JR,et al.Low-grade chronic inflammation in wo men with polycystic ovarian syndrome[J].J Clin Endocrinol Metab,2001,86:2453-2455.
  • 4Puder JJ,Varga S,Kraenzlin M,et al.Central fat excess in polycystic ovary syndrome:relationto low-grade inflammation and insulin resistance[J].J Clin Endocrinol Metab,2005,90:6014-6021.
  • 5The Rotterdam ESHRE-ASRM-sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J].Hum Reprod,2004,19(1):41-47.
  • 6中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 7戴吉茹,王蕊,梁竹巍.多囊卵巢综合征患者CRP、hsCRP的变化与心血管疾病的相关性分析[J].中国妇幼保健,2009,24(6):756-758. 被引量:5
  • 8Apridonidze T,Essah PA,Iuorno MJ,et al.Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90:1929-1935.
  • 9Mohlig M,Spranger J,Osterhoff M,et al.The polycystic ovary syndrome per se is not associated with increased chronic inflammation[J].Eur J Endocrinol,2004,150:525-532.
  • 10Thomann R,Rossinelli N,Keller U,et al.Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome[J].Gynecol Endocrinol,2008,24:199-206.

二级参考文献14

  • 1李爱群,吴寿岭,元小冬,翟文杰,于立群,陈昕丽,李秋云,袁宝军,纪民惠,史丽平.2型糖尿病患者血清高敏C反应蛋白水平与代谢综合征的相关性研究[J].中国糖尿病杂志,2006,14(1):32-34. 被引量:21
  • 2Engin - Ustun Y, Ustun Y, Meydanli MM, et al. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome [J]? Gynecol Endoerinol, 2006, 22:324.
  • 3Diamanti - Kandarakis E, Paterakis T, Kandarakis HA. Indices of low - grade inflammation in polycystic ovary syndrome [ J ] . Ann NY Acad Sci, 2006, 1092:175/
  • 4Yu H, Rifai N. High sensitivity C reactive protein and atherosclerosis:from theory to therapy [J] . Clin Biochem, 2000, 33:601.
  • 5Teede HJ, Meyer C, Norman RJ. Insulin - sensitisers in the treatment of polycystic ovary syndrome [J] . Expertopin Pharmacother, 2005, 6 (14) : 2419.
  • 6Baillargeon JP, Nestler JE. Polycystic ovary syndrome : a syndrome of ovarian hypersensity to insulin [J] ? Clin Endocrinol Metab, 2005, 10 (1) : 1804.
  • 7Martens JW, Geller DH, Arh W. Enzymatic activities of P450 α 17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome [J] .Clin Endocrinol Metab, 2000, 85 (11): 4338.
  • 8Bonna KH. An alternative hypothesis explaining the gender differences in risk of coronary heart disease [ J ] . Tidsskr Nor Laegeforen, 2002,122:1783.
  • 9Solomon CG, Hu FB, Dinaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease [ J ] . J Clin Endocmnol Metab, 2002, 87:2013.
  • 10Dahlgren E, Janson PO, Johanson S, et al. Polycystic ovary syndrome and risk for myocardial infarction [ J ] . Acta Obstet Gynecol Scand, 1992, 71:599.

共引文献3062

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部